ROTS: Reproducible RNA-seq biomarker detector - Prognostic markers for clear cell renal cell cancer

Nucleic Acids Research

Volumn 44, Issue 1, 2016, Pages e1-

  Seyednasrollah, Fatemeh ^a   Rantanen, Krista ^a   Jaakkola, Panu ^a,b   Elo, Laura L ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 2; TUMOR MARKER;

ALDOB GENE; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EPO GENE; FABP1 GENE; FALSE POSITIVE RESULT; G6PC GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; IGFBP1 GENE; KIDNEY CARCINOMA; PKLR GENE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REN GENE; REPRODUCIBILITY; RNA SEQUENCE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SLC2A2 GENE; ALGORITHM; BIOLOGY; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; INFORMATION PROCESSING; INTERNET; KAPLAN MEIER METHOD; KIDNEY TUMOR; MORTALITY; PROCEDURES; PROGNOSIS; SOFTWARE; STANDARDS; STATISTICAL MODEL;

ALGORITHMS; BIOMARKERS, TUMOR; CARCINOMA, RENAL CELL; COMPUTATIONAL BIOLOGY; DATASETS AS TOPIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INTERNET; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MODELS, STATISTICAL; PROGNOSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SOFTWARE;

EID: 84959452344     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv806     Document Type: Article

References (39)

1. Seqc/Maqc-Iii Consortium. (2014) A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium. Nat. Biotechnol., 32, 903-914.
2. Li,S., Labaj,P.P., Zumbo,P., Sykacek,P., Shi,W., Shi,L., Phan,J., Wu,P.-Y., Wang,M., Wang,C. et al. (2014) Detecting and correcting systematic variation in large-scale RNA sequencing data. Nat. Biotechnol., 32, 888-895.
3. Wang,C., Gong,B., Bushel,P.R., Thierry-Mieg,J., Thierry-Mieg,D., Xu,J., Fang,H., Hong,H., Shen,J., Su,Z. et al. (2014) The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance. Nat. Biotechnol., 32, 926-932.
4. Li,S., Tighe,S.W., Nicolet,C.M., Grove,D., Levy,S., Farmerie,W., Viale,A., Wright,C., Schweitzer,P.A., Gao,Y. et al. (2014) Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study. Nat. Biotechnol., 32, 915-925.
5. Robinson,M.D., McCarthy,D.J. and Smyth,G.K. (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinforma. Oxf. Engl., 26, 139-140.
6. McCarthy,D.J., Chen,Y. and Smyth,G.K. (2012) Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res., 40, 4288-4297.
7. Anders,S. and Huber,W. (2010) Differential expression analysis for sequence count data. Genome Biol., 11, R106.
8. Hardcastle,T.J. and Kelly,K.A. (2010) baySeq: Empirical Bayesian methods for identifying differential expression in sequence count data. BMC Bioinformatics, 11, 422.
9. Trapnell,C., Hendrickson,D.G., Sauvageau,M., Goff,L., Rinn,J.L. and Pachter,L. (2013) Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol., 31, 46-53.
10. Seyednasrollah,F., Laiho,A. and Elo,L.L. (2015) Comparison of software packages for detecting differential expression in RNA-seq studies. Brief. Bioinform., 16,59-70.
11. Rapaport,F., Khanin,R., Liang,Y., Pirun,M., Krek,A., Zumbo,P., Mason,C.E., Socci,N.D. and Betel,D. (2013) Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data. Genome Biol., 14, R95.
12. Soneson,C. and Delorenzi,M. (2013) A comparison of methods for differential expression analysis of RNA-seq data. BMC Bioinformatics, 14, 91.
13. Elo,L.L., Filen,S., Lahesmaa,R. and Aittokallio,T. (2008) Reproducibility-optimized test statistic for ranking genes in microarray studies. IEEE/ACM Trans. Comput. Biol. Bioinform., 5, 423-431.
14. Elo,L.L., Hiissa,J., Tuimala,J., Kallio,A., Korpelainen,E. and Aittokallio,T. (2009) Optimized detection of differential expression in global profiling experiments: case studies in clinical transcriptomic and quantitative proteomic datasets. Brief. Bioinform., 10, 547-555.
15. Jiang,L., Schlesinger,F., Davis,C.A., Zhang,Y., Li,R., Salit,M., Gingeras,T.R. and Oliver,B. (2011) Synthetic spike-in standards for RNA-seq experiments. Genome Res., 21, 1543-1551.
16. Kim,D., Pertea,G., Trapnell,C., Pimentel,H., Kelley,R. and Salzberg,S.L. (2013) TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol., 14, R36.
17. Anders,S., Pyl,P.T. and Huber,W. (2015) HTSeq - a Python framework to work with high-throughput sequencing data. Bioinformatics, 31, 166-169.
18. The Cancer Genome Atlas Research Network. (2013) Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499, 43-49.
19. Sato,Y., Yoshizato,T., Shiraishi,Y., Maekawa,S., Okuno,Y., Kamura,T., Shimamura,T., Sato-Otsubo,A., Nagae,G., Suzuki,H. et al. (2013) Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet., 45, 860-867.
20. Bullard,J.H., Purdom,E., Hansen,K.D. and Dudoit,S. (2010) Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC Bioinformatics, 11, 94.
21. Dillies,M.-A., Rau,A., Aubert,J., Hennequet-Antier,C., Jeanmougin,M., Servant,N., Keime,C., Marot,G., Castel,D., Estelle,J. et al. (2013) A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis. Brief. Bioinform., 14, 671-683.
22. Law,C.W., Chen,Y., Shi,W. and Smyth,G.K. (2014) voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol., 15, R29.
23. Tusher,V.G., Tibshirani,R. and Chu,G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A., 98, 5116-5121.
24. Shaughnessy,J.D., Zhan,F., Burington,B.E., Huang,Y., Colla,S., Hanamura,I., Stewart,J.P., Kordsmeier,B., Randolph,C., Williams,D.R. et al. (2007) A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood, 109, 2276-2284.
25. Love,M.I., Huber,W. and Anders,S. (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 550.
26. Smyth,G.K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol., 3, Article3.
27. Ritchie,M.E., Phipson,B., Wu,D., Hu,Y., Law,C.W., Shi,W. and Smyth,G.K. (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res., 43, e47-e47.
28. Li,J., Witten,D.M., Johnstone,I.M. and Tibshirani,R. (2012) Normalization, testing, and false discovery rate estimation for RNA-sequencing data. Biostat. Oxf. Engl., 13, 523-538.
29. Tarazona,S., García-Alcalde,F., Dopazo,J., Ferrer,A. and Conesa,A. (2011) Differential expression in RNA-seq: A matter of depth. Genome Res., 21, 2213-2223.
30. Rini,B.I., Campbell,S.C. and Escudier,B. (2009) Renal cell carcinoma. Lancet, 373, 1119-1132.
31. Zigeuner,R., Hutterer,G., Chromecki,T., Imamovic,A., Kampel-Kettner,K., Rehak,P., Langner,C. and Pummer,K. (2010) External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. Eur. Urol., 57, 102-109.
32. Chin,A.I., Lam,J.S., Figlin,R.A. and Belldegrun,A.S. (2006) Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev. Urol., 8, 1-7.
33. Van Laar,R., Flinchum,R., Brown,N., Ramsey,J., Riccitelli,S., Heuck,C., Barlogie,B. and Shaughnessy,J.D. (2014) Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use. BMC Med. Genomics, 7, 25.
34. Raval,R.R., Lau,K.W., Tran,M.G.B., Sowter,H.M., Mandriota,S.J., Li,J.-L., Pugh,C.W., Maxwell,P.H., Harris,A.L. and Ratcliffe,P.J. (2005) Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol. Cell. Biol., 25, 5675-5686.
35. Shen,C., Beroukhim,R., Schumacher,S.E., Zhou,J., Chang,M., Signoretti,S. and Kaelin,W.G. (2011) Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene. Cancer Discov., 1, 222-235.
36. Brannon,A.R., Reddy,A., Seiler,M., Arreola,A., Moore,D.T., Pruthi,R.S., Wallen,E.M., Nielsen,M.E., Liu,H., Nathanson,K.L. et al. (2010) Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns. Genes Cancer, 1, 152-163.
37. Kapur,P., Peña-Llopis,S., Christie,A., Zhrebker,L., Pavía-Jiménez,A., Rathmell,W.K., Xie,X.-J. and Brugarolas,J. (2013) Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. Lancet Oncol., 14, 159-167.
38. Patard,J.-J., Rioux-Leclercq,N., Masson,D., Zerrouki,S., Jouan,F., Collet,N., Dubourg,C., Lobel,B., Denis,M. and Fergelot,P. (2009) Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma. Br. J. Cancer, 101, 1417-1424.
39. Yao,M., Yoshida,M., Kishida,T., Nakaigawa,N., Baba,M., Kobayashi,K., Miura,T., Moriyama,M., Nagashima,Y., Nakatani,Y. et al. (2002) VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma. J. Natl. Cancer Inst., 94, 1569-1575.